Additionally, disruption of NF-κB signaling by transfection of an IκBα dominant-negative mutant or treatment with a NF-κB inhibitor abrogated the ability of AGK-overexpressing cells to promote angiogenesis in HUVECs and reduced the resistance of HCC cells to apoptosis. The gene discussed is NFKBIA; the disease is hepatocellular carcinoma.